Blocking malaria transmission by treating surfaces that mosquitoes contact
Malaria transmission blocking through mosquito contact with treated surfaces
This study is exploring a new way to help prevent malaria by putting special antimalarial compounds on surfaces where mosquitoes like to land, so they can absorb these compounds and reduce the chances of spreading malaria, especially in areas where mosquitoes are resistant to traditional insecticides.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard School of Public Health NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10768556 on NIH RePORTER |
What this research studies
This research investigates a novel approach to malaria prevention by applying antimalarial compounds to surfaces that female Anopheles mosquitoes frequently land on. The goal is to reduce malaria transmission by allowing mosquitoes to absorb these compounds through their legs, similar to how they uptake insecticides from treated nets and walls. The study builds on previous findings and aims to develop effective strategies that can complement existing malaria control methods, especially in regions facing insecticide resistance. By testing the effectiveness of this method in controlled environments, the research seeks to provide a new tool in the fight against malaria.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research are individuals living in malaria-endemic regions, particularly in sub-Saharan Africa.
Not a fit: Patients living in non-endemic regions or those who do not have exposure to malaria are unlikely to benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce malaria transmission rates, leading to better health outcomes in affected populations.
How similar studies have performed: Previous research has shown promise in using insecticide-treated surfaces for malaria control, but this specific approach of using antimalarials is relatively novel.
Where this research is happening
Boston, United States
- Harvard School of Public Health — Boston, United States (Active)
Researchers
- Principal investigator: Catteruccia, Flaminia — Harvard School of Public Health
- Study coordinator: Catteruccia, Flaminia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.